These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 25215625)

  • 21. Wiring the depressed brain: optogenetic and chemogenetic circuit interrogation in animal models of depression.
    Muir J; Lopez J; Bagot RC
    Neuropsychopharmacology; 2019 May; 44(6):1013-1026. PubMed ID: 30555161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optogenetic interrogations of the neural circuits underlying addiction.
    Britt JP; Bonci A
    Curr Opin Neurobiol; 2013 Aug; 23(4):539-45. PubMed ID: 23375167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depression: the search for separable behaviors and circuits.
    Post RJ; Warden MR
    Curr Opin Neurobiol; 2018 Apr; 49():192-200. PubMed ID: 29529482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression uncouples brain hate circuit.
    Tao H; Guo S; Ge T; Kendrick KM; Xue Z; Liu Z; Feng J
    Mol Psychiatry; 2013 Jan; 18(1):101-11. PubMed ID: 21968929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inferring neural circuit properties from optogenetic stimulation.
    Avery M; Nassi J; Reynolds J
    PLoS One; 2018; 13(10):e0205386. PubMed ID: 30365490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optogenetic approaches to evaluate striatal function in animal models of Parkinson disease.
    Parker KL; Kim Y; Alberico SL; Emmons EB; Narayanan NS
    Dialogues Clin Neurosci; 2016 Mar; 18(1):99-107. PubMed ID: 27069384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developments from Bulk Optogenetics to Single-Cell Strategies to Dissect the Neural Circuits that Underlie Aberrant Motivational States.
    Rodriguez-Romaguera J; Namboodiri VMK; Basiri ML; Stamatakis AM; Stuber GD
    Cold Spring Harb Perspect Med; 2022 Mar; 12(3):. PubMed ID: 32513671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishing causality for dopamine in neural function and behavior with optogenetics.
    Steinberg EE; Janak PH
    Brain Res; 2013 May; 1511():46-64. PubMed ID: 23031636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiscale Neuroscience of Psychiatric Disorders.
    van den Heuvel MP; Scholtens LH; Kahn RS
    Biol Psychiatry; 2019 Oct; 86(7):512-522. PubMed ID: 31320130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of Pedunculopontine Glutamate Neurons Is Reinforcing.
    Yoo JH; Zell V; Wu J; Punta C; Ramajayam N; Shen X; Faget L; Lilascharoen V; Lim BK; Hnasko TS
    J Neurosci; 2017 Jan; 37(1):38-46. PubMed ID: 28053028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Closed-loop and activity-guided optogenetic control.
    Grosenick L; Marshel JH; Deisseroth K
    Neuron; 2015 Apr; 86(1):106-39. PubMed ID: 25856490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Next-generation transgenic mice for optogenetic analysis of neural circuits.
    Asrican B; Augustine GJ; Berglund K; Chen S; Chow N; Deisseroth K; Feng G; Gloss B; Hira R; Hoffmann C; Kasai H; Katarya M; Kim J; Kudolo J; Lee LM; Lo SQ; Mancuso J; Matsuzaki M; Nakajima R; Qiu L; Tan G; Tang Y; Ting JT; Tsuda S; Wen L; Zhang X; Zhao S
    Front Neural Circuits; 2013; 7():160. PubMed ID: 24324405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Illuminating Neural Circuits: From Molecules to MRI.
    Lee JH; Kreitzer AC; Singer AC; Schiff ND
    J Neurosci; 2017 Nov; 37(45):10817-10825. PubMed ID: 29118210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optogenetic approaches for investigating neural pathways implicated in schizophrenia and related disorders.
    Cho KK; Sohal VS
    Hum Mol Genet; 2014 Sep; 23(R1):R64-8. PubMed ID: 24824218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The neural network underlying incentive-based learning: implications for interpreting circuit disruptions in psychiatric disorders.
    Haber SN; Behrens TE
    Neuron; 2014 Sep; 83(5):1019-39. PubMed ID: 25189208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virogenetic and optogenetic mechanisms to define potential therapeutic targets in psychiatric disorders.
    Han MH; Friedman AK
    Neuropharmacology; 2012 Jan; 62(1):89-100. PubMed ID: 21945288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain connectivity in psychiatric imaging genetics.
    Tost H; Bilek E; Meyer-Lindenberg A
    Neuroimage; 2012 Oct; 62(4):2250-60. PubMed ID: 22100419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroanatomic substrates of late-life mental disorders.
    Narayan M; Bremner JD; Kumar A
    J Geriatr Psychiatry Neurol; 1999; 12(3):95-106. PubMed ID: 10593698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optogenetics to study the circuits of fear- and depression-like behaviors: a critical analysis.
    Belzung C; Turiault M; Griebel G
    Pharmacol Biochem Behav; 2014 Jul; 122():144-57. PubMed ID: 24727401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. All-optical approaches to studying psychiatric disease.
    Lafferty CK; Christinck TD; Britt JP
    Methods; 2022 Jul; 203():46-55. PubMed ID: 34314828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.